Interestingly, we found that Gli1 was significantly up‐regulated in breast cancer tissues, whereas PTCH1, SMO, Gli1 and HHIP at mRNA and protein levels were all down‐regulated after controlling for EGOT overexpression (Fig. 3). Here, SMO is linked to breast carcinoma.